ST. LOUIS–(BUSINESS WIRE)–PierianDx announced today that six leading healthcare systems andacademic medical centers have chosen its leading “One Space” genomicssoftware solution, CGW, to streamline clinical lab workflow, analysis,interpretation and reporting. More than 40 members of the PierianDxPartner Sharing Network utilize the shared constitutional and somaticgenomic data within CGW to target patient-specific diagnosis andtreatments for cancers and hereditary diseases.
PierianDx’s new customers include: Cedars-Sinai Medical Center,Dartmouth-Hitchcock Medical Center, Florida Hospital, Georgia Esoteric &Molecular Laboratory at Augusta University, Northshore UniversityHealthSystem, and the University of Arkansas for Medical Sciences (UAMS).
“We are excited that so many leaders in precision medicine have chosenour unified workspace solution,” said PierianDx CEO Ted Briscoe. “Healthsystems and medical centers are quickly recognizing that they need asingle, integrated workspace to address the accelerated NGS testingneeds of their physicians and patients.”
Every new PierianDx customer becomes part of a larger network thatshares clinical interpretations across patient cases and patientpopulations, which feeds a knowledgebase comprised of millions ofbiomedical findings. The network has also evolved to share bestpractices for accelerating next generation sequencing (NGS) testingwithin their organizations.
“The engine that drives our knowledgebase and technology platform is ourwell-established partner network,” added Briscoe. “Collaborative datasharing is key to advancing precision medicine.”
PierianDx enables clinical labs to deliver patient-specific diagnosisand treatments based on an individual’s DNA for cancers and hereditarydiseases. Utilizing PierianDx’s comprehensive and integrated “One Space”workflow and analysis solution, Clinical Genomicist Workspace (CGW),clinical labs create more streamlined and accurate analysis,interpretation, and reporting needed to accelerate their personalizedmedicine programs. For more information, please visit www.pieriandx.comor @PierianDx on Twitter.